Author Details

Amonkar, M.M., GlaxoSmithKline, United States

  • Vol 20, No 5 (2013) - Medical Economics
    Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada
    Abstract  PDF  HTML